Page last updated: 2024-09-03

ezogabine and Genetic Predisposition

ezogabine has been researched along with Genetic Predisposition in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bock, M; Danker, T; De Jonghe, P; Guenther, E; Ilina, EI; Jezutkovic, N; Lerche, H; Löffler, H; Maljevic, S; Mandelstam, S; Orhan, G; Reichel, SN; Scheffer, IE; Schepers, D; Suls, A; Weckhuysen, S1
Frankel, WN; Otto, JF; White, HS; Wilcox, KS; Yang, Y1

Other Studies

2 other study(ies) available for ezogabine and Genetic Predisposition

ArticleYear
Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathy.
    Annals of neurology, 2014, Volume: 75, Issue:3

    Topics: Animals; Carbamates; Epilepsy, Benign Neonatal; Genetic Predisposition to Disease; Humans; KCNQ2 Potassium Channel; Membrane Potentials; Mutation, Missense; Oocytes; Phenylenediamines; Potassium Channels, Voltage-Gated; Xenopus

2014
Mice carrying the szt1 mutation exhibit increased seizure susceptibility and altered sensitivity to compounds acting at the m-channel.
    Epilepsia, 2004, Volume: 45, Issue:9

    Topics: Animals; Anticonvulsants; Carbamates; Disease Models, Animal; Electroshock; Female; Genetic Predisposition to Disease; Indoles; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Mutant Strains; Mutation; Nerve Tissue Proteins; Phenylenediamines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Pyridines; Receptors, Nicotinic; Seizures; Sequence Deletion

2004